Sheng Ma
- Biomedical Engineering top 5%
- Immunology top 5%
- Molecular Biology
- Biomaterials top 5%
- Oncology top 10%
- Co-authors
- Wantong SongZhaohui TangXinghui SiYudi XuXuesi ChenJiayu ZhaoZichao HuangYu Zhang
- Topics
- Immunotherapy and Immune Responses (12 papers)Nanoplatforms for cancer theranostics (12 papers)Cancer Immunotherapy and Biomarkers (9 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Sheng Ma
45 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 106
- Biomedical Engineering 659
- Immunology 553
- Molecular Biology 451
- Biomaterials 349
- Oncology 271
Countries citing papers authored by Sheng Ma
This map shows the geographic impact of Sheng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Ma more than expected).
Fields of papers citing papers by Sheng Ma
This network shows the impact of papers produced by Sheng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Ma. The network helps show where Sheng Ma may publish in the future.
Co-authorship network of co-authors of Sheng Ma
This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Ma. A scholar is included among the top collaborators of Sheng Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Ma. Sheng Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 8 | |
| 6 | 13 | |
| 7 | 6 | |
| 8 | 2 | |
| 9 | 25 | |
| 10 | 4 | |
| 11 | 17 | |
| 12 | 19 | |
| 13 | 5 | |
| 14 | 18 | |
| 15 | 14 | |
| 16 | 63 | |
| 17 | 1 | |
| 18 | 64 | |
| 19 | 84 | |
| 20 | 20 |
About Sheng Ma
Sheng Ma is a scholar working on Immunology, Biomaterials and Filtration and Separation, having authored 50 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), Nanoplatforms for cancer theranostics (12 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Biomaterials (349 citations), Immunology (553 citations) and Biomedical Engineering (659 citations). Sheng Ma has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Wantong Song, Zhaohui Tang, Xinghui Si, Yudi Xu, Xuesi Chen, Jiayu Zhao, Zichao Huang, Yu Zhang, Shixian Lv and Haochen Yao. Their work appears in journals such as Advanced Materials, Nano Letters and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.